EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada

Danuta M Skowronski iD, Charlene Ranadheera, Samantha E Kaweski, Suzana Sabaiduc, Lea Separovic, Gaby Makowski, Johnny Ung, Romina C Reyes iD, Bonnie Henry, Arianne Albert, Felicity Clemens, Darwyn Kobasa und 1 weitere

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Danuta M Skowronski und 12 weiteren Autor:innen. Beteiligte Einrichtung: Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Influenza, Human, Influenza A Virus, H5N1 Subtype, Neuraminidase, Antibodies, Viral. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Public Health Agency of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preexisting immunity to emerging influenza viruses informs pandemic risk assessment. We compared cross-reactive neuraminidase antibody levels against avian influenza A(H5N1) by age and birth (imprinting) cohorts defined by periods of human influenza A subtype (H1N1, H2N2, or H3N2) circulation over the past century.

Methods

We used anonymized residual sera collected from 10 age groups spanning 1 to >80 years during an August 2024 cross-sectional serosurvey conducted in British Columbia, Canada. We assessed neuraminidase inhibition antibody titers by enzyme-linked lectin assay against clade 2.3.4.4b H5N1 and 2009-H1N1pdm09 and 1968 H3N2 pandemic strains.

Results

Among 575 participants with a median age of 32 years (IQR, 15–62), 404 (70%) had detectable anti-N1 titers ≥10 against H5N1, with 260 (45%), 182 (32%), and 98 (17%) having titers ≥40, ≥80, and ≥160, respectively. Anti-N1 titers against 2009-H1N1pdm09 and H5N1 were strongly correlated (r = 0.86; 95% CI, .82–.89): highest among young adults born 1997 to 2003 who were school-aged children during the 2009 H1N1 pandemic (427.9, 100.8); lowest among the least influenza-experienced pediatric cohorts born 2015 to 2023 (20.7, 6.8) and middle-aged adults born during the 1957–1967 H2N2 era (25.1, 10.7); increasing toward a similar secondary peak among the oldest cohorts born during the pre-1947 H1N1 era (387.3, 81.0).

Conclusions

A substantial proportion of the population has preexisting anti-N1 against H5N1, with age-related variation reflecting H1N1 imprinting and exposure opportunities. Through heightened attack rates and shifts in immunologic hierarchies, historical pandemics shape and expand the immune repertoire influencing potential preimmunity to emerging zoonotic threats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza A Virus, H5N1 SubtypeNeuraminidaseAntibodies, ViralHumansAdultMiddle AgedAdolescentCross ReactionsChildChild, PreschoolYoung AdultFemaleInfantAgedMaleBritish ColumbiaAged, 80 and overCross-Sectional StudiesInfluenza A Virus, H3N2 SubtypeAge FactorsInfluenza A Virus, H1N1 SubtypeSeroepidemiologic StudiesInfluenza A Virus, H2N2 Subtype

Stichwörter der Autor:innen

H5N1antibodyimprintinginfluenzaneuraminidase

Substanzen

NeuraminidaseAntibodies, Viral

Autor:innen und Institutionen

  • Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Influenza, Respiratory Virus and Coronavirus Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Medical Scientific Department, LifeLabs, Burnaby, British Columbia, Canada.
  • Office of the Provincial Health Officer, Ministry of Health, Victoria, British Columbia, Canada.
  • Epidemiology and Intelligence Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

ORCID-Profile: Danuta M Skowronski, Romina C Reyes

Förderung

  • Public Health Agency of Canada

Zitieren

APA

Skowronski, D. M., Ranadheera, C., Kaweski, S. E., Sabaiduc, S., Separovic, L., Makowski, G., Ung, J., Reyes, R. C., Henry, B., Albert, A., Clemens, F., Kobasa, D., & Bastien, N. (2026). Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag030

Vancouver

Skowronski DM, Ranadheera C, Kaweski SE, Sabaiduc S, Separovic L, Makowski G, et al. Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag030

BibTeX
@article{Skowronski2026,
  author = {Skowronski, Danuta M and Ranadheera, Charlene and Kaweski, Samantha E and Sabaiduc, Suzana and Separovic, Lea and Makowski, Gaby and Ung, Johnny and Reyes, Romina C and Henry, Bonnie and Albert, Arianne and Clemens, Felicity and Kobasa, Darwyn and Bastien, Nathalie},
  title = {Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag030}
}
Kostenlos starten →